DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS

DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS was reported 380 times

DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SPINAL MENINGIOMA BENIGN 2 0.0377
1 FEMALE SEX HORMONE LEVEL ABNORMAL 1 0.0227
2 DECIDUAL CAST 1 0.0200
3 ORBITAL SWELLING 1 0.0172
4 INTRACARDIAC PRESSURE INCREASED 1 0.0114
5 HABITUAL ABORTION 1 0.0088
6 UTERINE ADHESIONS 1 0.0078
7 SACROILIAC JOINT DYSFUNCTION 1 0.0075
8 NOCTURNAL FEAR 1 0.0072
9 PINEAL GLAND CYST 1 0.0071
10 TANNING 1 0.0068
11 BLOOD INSULIN DECREASED 1 0.0065
12 BLOOD COPPER INCREASED 1 0.0056
13 PREMENSTRUAL DYSPHORIC DISORDER 1 0.0049
14 HERNIA HIATUS REPAIR 1 0.0049
15 HAEMORRHOID OPERATION 2 0.0045
16 ADENOTONSILLECTOMY 1 0.0040
17 LAPAROSCOPY 1 0.0038
18 GALLBLADDER OBSTRUCTION 1 0.0038
19 SUDDEN VISUAL LOSS 1 0.0036
20 CENTRAL SLEEP APNOEA SYNDROME 1 0.0031
21 ILEECTOMY 1 0.0030
22 PRODUCT SUBSTITUTION 1 0.0025
23 FIBROADENOMA OF BREAST 1 0.0022
24 PERINATAL DEPRESSION 1 0.0022
25 HEPATIC ADENOMA 1 0.0019
26 ASPARTATE AMINOTRANSFERASE DECREASED 1 0.0019
27 ENDOMETRIAL THICKENING 1 0.0018
28 TONSILLAR DISORDER 2 0.0018
29 ALLODYNIA 2 0.0017
30 CORTISOL INCREASED 1 0.0016
31 MAGNETIC RESONANCE IMAGING HEAD ABNORMAL 1 0.0015
32 SARS-COV-2 TEST NEGATIVE 1 0.0015
33 CENTRAL NERVOUS SYSTEM LYMPHOMA 2 0.0015
34 INGROWN HAIR 1 0.0014
35 OPHTHALMIC MIGRAINE 1 0.0014
36 PARASOMNIA 1 0.0014
37 ALANINE AMINOTRANSFERASE DECREASED 1 0.0014
38 SYMPTOM MASKED 1 0.0014
39 WITHDRAWAL BLEED 1 0.0014
40 VITAMIN B COMPLEX DEFICIENCY 1 0.0013
41 SYSTEMIC LUPUS ERYTHEMATOSUS RASH 1 0.0013
42 INTERMENSTRUAL BLEEDING 7 0.0013
43 COLON CANCER METASTATIC 2 0.0012
44 ALTERED VISUAL DEPTH PERCEPTION 1 0.0012
45 CEREBRAL VENOUS THROMBOSIS 2 0.0011
46 TUMOUR HAEMORRHAGE 3 0.0011
47 TELANGIECTASIA 1 0.0010
48 HYPERVIGILANCE 1 0.0010
49 HAEMANGIOMA OF LIVER 1 0.0010
50 BRAIN STEM INFARCTION 1 0.0010
51 GASTRIC CANCER STAGE IV 2 0.0009
52 RIGHT VENTRICULAR DYSFUNCTION 1 0.0009
53 ADMINISTRATION SITE PAIN 1 0.0009
54 POLYMENORRHOEA 3 0.0009
55 INFUSION SITE INFECTION 2 0.0009
56 DYSFUNCTIONAL UTERINE BLEEDING 1 0.0008
57 XEROSIS 1 0.0008
58 INFUSION SITE IRRITATION 1 0.0008
59 GASTROENTERITIS NOROVIRUS 1 0.0008
60 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 1 0.0007
61 CARBON DIOXIDE INCREASED 1 0.0007
62 ELECTRIC SHOCK SENSATION 2 0.0007
63 CATAPLEXY 1 0.0007
64 OSTEOMALACIA 1 0.0006
65 POLYCYSTIC OVARIES 1 0.0006
66 ONYCHOLYSIS 1 0.0006
67 RESPIRATORY RATE DECREASED 2 0.0006
68 INFUSION SITE PRURITUS 2 0.0006
69 INAPPROPRIATE AFFECT 1 0.0006
70 NIGHT BLINDNESS 1 0.0006
71 OROPHARYNGEAL BLISTERING 1 0.0006
72 BRADYARRHYTHMIA 1 0.0006
73 SEBORRHOEIC DERMATITIS 1 0.0006
74 PRODUCT COUNTERFEIT 1 0.0006
75 HYPOPNOEA 2 0.0006
76 FOOD INTERACTION 1 0.0006
77 PANCREATIC FAILURE 1 0.0006
78 DYSMENORRHOEA 7 0.0005
79 METRORRHAGIA 9 0.0005
80 NASAL SEPTUM DEVIATION 1 0.0005
81 LIBIDO INCREASED 1 0.0005
82 REBOUND ECZEMA 1 0.0005
83 IMPULSE-CONTROL DISORDER 1 0.0005
84 ATTENTION DEFICIT HYPERACTIVITY DISORDER 2 0.0005
85 SLEEP DEFICIT 1 0.0005
86 DEREALISATION 1 0.0005
87 REACTION TO DRUG EXCIPIENTS 1 0.0005
88 CERVICAL DYSPLASIA 1 0.0005
89 ABDOMINAL ABSCESS 2 0.0005
90 TEMPERATURE REGULATION DISORDER 1 0.0004
91 APPLICATION SITE URTICARIA 1 0.0004
92 IDIOPATHIC INTRACRANIAL HYPERTENSION 1 0.0004
93 BRAIN OPERATION 1 0.0004
94 SINUS PAIN 1 0.0004
95 FOOT OPERATION 2 0.0004
96 EYELID IRRITATION 1 0.0004
97 SEDATION COMPLICATION 1 0.0004
98 ILEOSTOMY 1 0.0004
99 LACTOSE INTOLERANCE 1 0.0004
100 PREGNANCY ON ORAL CONTRACEPTIVE 1 0.0004
101 BREAST SWELLING 1 0.0004
102 BRUXISM 2 0.0004
103 MOOD ALTERED 10 0.0004
104 PRODUCT SUBSTITUTION ISSUE 21 0.0004
105 HYPOMENORRHOEA 1 0.0004
106 TRICHORRHEXIS 1 0.0004
107 MENSTRUATION IRREGULAR 9 0.0003
108 HEAVY MENSTRUAL BLEEDING 3 0.0003
109 EMBOLISM VENOUS 1 0.0003
110 INFUSION SITE SWELLING 2 0.0003
111 BLEPHAROSPASM 2 0.0003
112 VAGINAL DISCHARGE 3 0.0003
113 REPRODUCTIVE COMPLICATION ASSOCIATED WITH DEVICE 1 0.0003
114 PRODUCT SUPPLY ISSUE 2 0.0003
115 HYPOMANIA 1 0.0003
116 FEELING DRUNK 2 0.0003
117 NEURODERMATITIS 1 0.0003
118 BREAST TENDERNESS 2 0.0003
119 SNORING 1 0.0003
120 TENDON PAIN 2 0.0003
121 SLEEP APNOEA SYNDROME 5 0.0003
122 THYROID MASS 1 0.0003
123 THERAPEUTIC PRODUCT EFFECT VARIABLE 1 0.0003
124 EPIGASTRIC DISCOMFORT 1 0.0003
125 PRODUCT ADMINISTRATION INTERRUPTED 2 0.0003
126 AFFECTIVE DISORDER 2 0.0003
127 HYPERPHAGIA 1 0.0003
128 FRUSTRATION TOLERANCE DECREASED 2 0.0002
129 GOITRE 1 0.0002
130 GENERALISED TONIC-CLONIC SEIZURE 4 0.0002
131 PURULENT DISCHARGE 1 0.0002
132 SHOULDER OPERATION 1 0.0002
133 PSEUDOMONAS INFECTION 2 0.0002
134 TEARFULNESS 1 0.0002
135 CATHETERISATION CARDIAC 1 0.0002
136 IRON DEFICIENCY 1 0.0002
137 PELVIC PAIN 4 0.0002
138 MOOD SWINGS 7 0.0002
139 DYSPAREUNIA 1 0.0002
140 ROSACEA 1 0.0002
141 VAGINAL INFECTION 1 0.0002
142 HORMONE LEVEL ABNORMAL 1 0.0002
143 SKIN HAEMORRHAGE 3 0.0002
144 GASTROINTESTINAL SOUNDS ABNORMAL 1 0.0002
145 DYSPHORIA 1 0.0002
146 BRAIN FOG 3 0.0002
147 BREAST PAIN 2 0.0002
148 AUTISM SPECTRUM DISORDER 1 0.0002
149 CHOKING SENSATION 1 0.0002
150 CYSTIC FIBROSIS 1 0.0002
151 PERIORBITAL SWELLING 1 0.0002
152 GENERALISED ERYTHEMA 1 0.0002
153 MICTURITION URGENCY 2 0.0002
154 SOCIAL AVOIDANT BEHAVIOUR 1 0.0002
155 HYPERTRIGLYCERIDAEMIA 1 0.0002
156 ENERGY INCREASED 1 0.0002
157 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
158 SINUS HEADACHE 1 0.0002
159 SYMPTOM RECURRENCE 1 0.0002
160 DERMATITIS ACNEIFORM 1 0.0002
161 PRE-EXISTING CONDITION IMPROVED 1 0.0002
162 NASAL DRYNESS 1 0.0002
163 INFUSION SITE PAIN 2 0.0002
164 INCOHERENT 1 0.0002
165 SKIN FISSURES 3 0.0002
166 DERMATITIS ATOPIC 8 0.0002
167 PRODUCT FORMULATION ISSUE 1 0.0002
168 CORONAVIRUS INFECTION 1 0.0002
169 RESPIRATION ABNORMAL 1 0.0001
170 PAPULE 1 0.0001
171 RETCHING 3 0.0001
172 INTENTIONAL DOSE OMISSION 4 0.0001
173 IMPAIRED QUALITY OF LIFE 2 0.0001
174 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
175 INTENTIONAL UNDERDOSE 1 0.0001
176 MAJOR DEPRESSION 1 0.0001
177 MOUTH HAEMORRHAGE 1 0.0001
178 SUNBURN 1 0.0001
179 PAROSMIA 1 0.0001
180 DISSOCIATION 1 0.0001
181 INJECTION SITE RASH 4 0.0001
182 APNOEA 1 0.0001
183 MULTIPLE ALLERGIES 1 0.0001
184 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
185 CYANOSIS 2 0.0001
186 MIGRAINE 12 0.0001
187 NIGHT SWEATS 4 0.0001
188 DECUBITUS ULCER 1 0.0001
189 POLYURIA 1 0.0001
190 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
191 MENSTRUAL DISORDER 1 0.0001
192 EMBOLISM 1 0.0001
193 EYE PRURITUS 4 0.0001
194 SENSATION OF FOREIGN BODY 1 0.0001
195 SKIN PLAQUE 1 0.0001
196 UTERINE PERFORATION 1 0.0001
197 VITAMIN D DECREASED 1 0.0001
198 IRRITABILITY 7 0.0001
199 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
200 ECZEMA 6 0.0001
201 RASH MACULAR 4 0.0001
202 AMENORRHOEA 2 0.0001
203 EAR INFECTION 3 0.0001
204 FOREIGN BODY IN REPRODUCTIVE TRACT 1 0.0001
205 MYOSITIS 1 0.0001
206 LIP DRY 1 0.0001
207 CRYING 4 0.0001
208 OPTIC NEURITIS 1 0.0001
209 ABNORMAL DREAMS 3 0.0001
210 PRODUCT DISTRIBUTION ISSUE 1 0.0001
211 HEPATIC ENCEPHALOPATHY 1 0.0001
212 ABORTION INDUCED 1 0.0001
213 PAIN IN JAW 3 0.0001
214 FEELING JITTERY 2 0.0001
215 VITAMIN D DEFICIENCY 1 0.0001
216 COELIAC DISEASE 1 0.0001
217 MENORRHAGIA 2 0.0001
218 BODY TEMPERATURE DECREASED 1 0.0001
219 EMBEDDED DEVICE 1 0.0001
220 DRY EYE 5 0.0001
221 OVARIAN CYST 1 0.0001
222 PRODUCT PREPARATION ERROR 2 0.0001
223 VENTRICULAR EXTRASYSTOLES 1 0.0001
224 EYE DISCHARGE 1 0.0001
225 DERMATITIS 2 0.0001
226 FOLLICULITIS 1 0.0001
227 SKIN EXFOLIATION 8 0.0001
228 HEAD INJURY 3 0.0001
229 PULMONARY EMBOLISM 9 0.0001
230 DECREASED ACTIVITY 1 0.0001
231 PRURITUS GENERALISED 2 0.0001
232 ACNE 7 0.0001
233 MENSTRUATION DELAYED 1 0.0001
234 PRODUCT PRESCRIBING ISSUE 2 0.0001
235 PULMONARY THROMBOSIS 1 0.0001
236 GASTROINTESTINAL PAIN 1 0.0001
237 INJECTION SITE NODULE 1 0.0001
238 FISTULA 1 0.0001
239 ANGER 3 0.0001
240 SCAB 1 0.0001
241 SUICIDAL IDEATION 8 0.0001
242 MUSCLE RIGIDITY 1 0.0001
243 DEPRESSION 19 0.0001
244 PRESYNCOPE 2 0.0001
245 RESPIRATORY DEPRESSION 1 0.0001
246 FEELING HOT 5 0.0001
247 CARDIOMEGALY 1 0.0001
248 SECRETION DISCHARGE 1 0.0001
249 DYSPNOEA EXERTIONAL 3 0.0001
250 BRAIN OEDEMA 1 0.0001
251 BEDRIDDEN 1 0.0001
252 IMMUNE SYSTEM DISORDER 1 0.0001
253 ANKYLOSING SPONDYLITIS 1 0.0001
254 ABNORMAL BEHAVIOUR 3 0.0001
255 DEPRESSED MOOD 4 0.0001
256 ADVERSE REACTION 1 0.0001
257 DRY SKIN 10 0.0001
258 HAIR TEXTURE ABNORMAL 1 0.0001
259 QUALITY OF LIFE DECREASED 1 0.0001
260 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
261 APPLICATION SITE RASH 1 0.0001
262 APHONIA 1 0.0001
263 SKIN REACTION 1 0.0001
264 BLINDNESS UNILATERAL 1 0.0001
265 EYE PAIN 4 0.0001
266 HEART RATE INCREASED 7 0.0001
267 FLATULENCE 4 0.0001
268 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 5 0.0001
269 ANXIETY 20 0.0001
270 VAGINAL HAEMORRHAGE 3 0.0001
271 PULMONARY ARTERIAL HYPERTENSION 1 0.0001
272 SINUSITIS 7 0.0001
273 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
274 ABDOMINAL DISTENSION 7 0.0001
275 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
276 HEPATIC FAILURE 2 0.0001
277 EPILEPSY 2 0.0001
278 HYPOKALAEMIA 3 0.0001
279 MENINGIOMA 1 0.0001
280 PNEUMOTHORAX 1 0.0001
281 OBESITY 1 0.0001
282 MULTIPLE SCLEROSIS 3 0.0001
283 SCIATICA 1 0.0001
284 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
285 SENSORY DISTURBANCE 1 0.0001
286 MUSCLE TIGHTNESS 1 0.0001
287 PHOTOSENSITIVITY REACTION 1 0.0001
288 HYPOAESTHESIA 9 0.0001
289 SKIN DISORDER 2 0.0001
290 HEMIPARESIS 1 0.0001
291 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
292 THERAPY CESSATION 3 0.0001
293 SCAR 1 0.0001
294 PARANOIA 1 0.0001
295 PRODUCT DOSE OMISSION ISSUE 17 0.0001
296 SLEEP DISORDER 4 0.0001
297 HEAD DISCOMFORT 1 0.0001
298 INSOMNIA 15 0.0001
299 THIRST 1 0.0001
300 MOBILITY DECREASED 4 0.0001
301 COMPLICATION OF DEVICE REMOVAL 1 0.0001
302 RESTLESS LEGS SYNDROME 1 0.0001
303 PANIC ATTACK 2 0.0001
304 TREATMENT NONCOMPLIANCE 3 0.0001
305 DYSURIA 2 0.0001
306 ANAPHYLACTIC REACTION 3 0.0001
307 OROPHARYNGEAL PAIN 5 0.0001
308 DYSGEUSIA 4 0.0001
309 EYE SWELLING 2 0.0001
310 HOT FLUSH 4 0.0001
311 GASTRIC ULCER 1 0.0001
312 HERPES ZOSTER 3 0.0001
313 LETHARGY 3 0.0001
314 EAR PAIN 1 0.0001
315 SURGERY 3 0.0001
316 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
317 COMPLICATION OF DEVICE INSERTION 1 0.0001
318 FEELING ABNORMAL 12 0.0001
319 PRODUCT PHYSICAL ISSUE 1 0.0000
320 THERAPEUTIC RESPONSE DECREASED 3 0.0000
321 HEADACHE 31 0.0000
322 BODY TEMPERATURE INCREASED 1 0.0000
323 CHEST DISCOMFORT 5 0.0000
324 DRUG DOSE OMISSION 8 0.0000
325 HAEMORRHAGE 5 0.0000
326 MOUTH ULCERATION 1 0.0000
327 HALLUCINATION, VISUAL 1 0.0000
328 IMPAIRED WORK ABILITY 1 0.0000
329 RHINORRHOEA 3 0.0000
330 DEEP VEIN THROMBOSIS 3 0.0000
331 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
332 CONDITION AGGRAVATED 14 0.0000
333 INTENTIONAL PRODUCT USE ISSUE 4 0.0000
334 NAUSEA 36 0.0000
335 COLITIS ULCERATIVE 2 0.0000
336 VOMITING 21 0.0000
337 SNEEZING 1 0.0000
338 PANCREATITIS ACUTE 1 0.0000
339 PRODUCT USE IN UNAPPROVED INDICATION 11 0.0000
340 ERYTHEMA 9 0.0000
341 SKIN IRRITATION 2 0.0000
342 ABDOMINAL PAIN 10 0.0000
343 BURNING SENSATION 3 0.0000
344 OCULAR HYPERAEMIA 2 0.0000
345 DISEASE RECURRENCE 2 0.0000
346 PRODUCT PRESCRIBING ERROR 1 0.0000
347 RASH ERYTHEMATOUS 2 0.0000
348 MENTAL IMPAIRMENT 1 0.0000
349 NEURALGIA 1 0.0000
350 ABDOMINAL PAIN LOWER 1 0.0000
351 PRODUCT COMPLAINT 1 0.0000
352 FLUID RETENTION 2 0.0000
353 INJECTION SITE SWELLING 3 0.0000
354 PRURITUS 15 0.0000
355 UNRESPONSIVE TO STIMULI 1 0.0000
356 EXPOSURE VIA SKIN CONTACT 1 0.0000
357 DIPLOPIA 1 0.0000
358 MUSCLE SPASMS 7 0.0000
359 PARAESTHESIA 6 0.0000
360 DIZZINESS 19 0.0000
361 NASOPHARYNGITIS 7 0.0000
362 HYPERSENSITIVITY 7 0.0000
363 INJECTION SITE HAEMORRHAGE 3 0.0000
364 DIARRHOEA 24 0.0000
365 PAIN OF SKIN 1 0.0000
366 BLOOD BILIRUBIN INCREASED 1 0.0000
367 DRY MOUTH 3 0.0000
368 RASH 16 0.0000
369 INFLUENZA LIKE ILLNESS 3 0.0000
370 MEMORY IMPAIRMENT 5 0.0000
371 DIVERTICULITIS 1 0.0000
372 PROCEDURAL PAIN 1 0.0000
373 FEELING COLD 1 0.0000
374 NECK PAIN 2 0.0000
375 WOUND 1 0.0000
376 ABDOMINAL DISCOMFORT 6 0.0000
377 NEEDLE ISSUE 1 0.0000
378 PRODUCT STORAGE ERROR 3 0.0000
379 DRUG WITHDRAWAL SYNDROME 3 0.0000
380 PALPITATIONS 4 0.0000
381 NASAL CONGESTION 2 0.0000
382 GASTROINTESTINAL DISORDER 3 0.0000
383 OEDEMA PERIPHERAL 4 0.0000
384 VERTIGO 2 0.0000
385 DISCOMFORT 2 0.0000
386 EMOTIONAL DISORDER 1 0.0000
387 EXPOSURE DURING PREGNANCY 2 0.0000
388 FATIGUE 25 0.0000
389 SWOLLEN TONGUE 1 0.0000
390 DEVICE EXPULSION 2 0.0000
391 PRODUCT DOSE OMISSION 2 0.0000
392 CHOLELITHIASIS 1 0.0000
393 IMPAIRED HEALING 1 0.0000
394 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
395 EXPIRED PRODUCT ADMINISTERED 1 0.0000
396 VIRAL INFECTION 1 0.0000
397 DEHYDRATION 4 0.0000
398 INJECTION SITE PRURITUS 2 0.0000
399 URTICARIA 5 0.0000
400 MALAISE 13 0.0000
401 FLUSHING 3 0.0000
402 MYALGIA 5 0.0000
403 HEPATIC ENZYME INCREASED 2 0.0000
404 URINARY TRACT INFECTION 5 0.0000
405 ILLNESS 3 0.0000
406 INJECTION SITE REACTION 2 0.0000
407 NIGHTMARE 1 0.0000
408 NEOPLASM PROGRESSION 1 0.0000
409 HEART RATE DECREASED 1 0.0000
410 DYSPNOEA 16 0.0000
411 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
412 PRODUCT ADHESION ISSUE 1 0.0000
413 THERAPY INTERRUPTED 2 0.0000
414 SKIN BURNING SENSATION 2 0.0000
415 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5 0.0000
416 DRUG EFFECT INCOMPLETE 1 0.0000
417 CONSTIPATION 6 0.0000
418 RESTLESSNESS 1 0.0000
419 INJECTION SITE MASS 1 0.0000
420 BRONCHITIS 2 0.0000
421 CHEST PAIN 5 0.0000
422 THROMBOCYTOPENIA 3 0.0000
423 PRODUCT USE ISSUE 5 0.0000
424 DYSARTHRIA 1 0.0000
425 ASTHMA 3 0.0000
426 ANAEMIA 5 0.0000
427 SEIZURE 3 0.0000
428 CHILLS 3 0.0000
429 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
430 DISORIENTATION 1 0.0000
431 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
432 EXTRA DOSE ADMINISTERED 1 0.0000
433 DEVICE BREAKAGE 1 0.0000
434 DYSKINESIA 1 0.0000
435 ABDOMINAL PAIN UPPER 5 0.0000
436 INJECTION SITE ERYTHEMA 3 0.0000
437 WITHDRAWAL SYNDROME 1 0.0000
438 HYPERTENSION 5 0.0000
439 HYPERHIDROSIS 3 0.0000
440 DEVICE DISLOCATION 1 0.0000
441 MENTAL DISORDER 1 0.0000
442 PSORIASIS 3 0.0000
443 INTENTIONAL PRODUCT MISUSE 2 0.0000
444 COVID-19 4 0.0000
445 WEIGHT INCREASED 5 0.0000
446 DEVICE ISSUE 2 0.0000
447 PRODUCT QUALITY ISSUE 3 0.0000
448 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
449 VISION BLURRED 3 0.0000
450 TINNITUS 1 0.0000
451 ARTHRALGIA 9 0.0000
452 DECREASED APPETITE 5 0.0000
453 BACK PAIN 5 0.0000
454 BLOOD CHOLESTEROL INCREASED 1 0.0000
455 COGNITIVE DISORDER 1 0.0000
456 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1 0.0000
457 SWELLING 2 0.0000
458 CONTUSION 2 0.0000
459 LUNG DISORDER 1 0.0000
460 DYSPEPSIA 2 0.0000
461 SYNCOPE 2 0.0000
462 SOMNOLENCE 4 0.0000
463 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 4 0.0000
464 OFF LABEL USE 17 0.0000
465 INFLAMMATION 1 0.0000
466 DRUG EFFECT DECREASED 1 0.0000
467 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
468 INFLUENZA 2 0.0000
469 COUGH 5 0.0000
470 BLISTER 1 0.0000
471 CONVULSION 1 0.0000
472 EYE IRRITATION 1 0.0000
473 EMOTIONAL DISTRESS 2 0.0000
474 STOMATITIS 1 0.0000
475 ILL-DEFINED DISORDER 1 0.0000
476 INJECTION SITE PAIN 5 0.0000
477 VISUAL IMPAIRMENT 2 0.0000
478 AMNESIA 1 0.0000
479 SWELLING FACE 1 0.0000
480 ALOPECIA 3 0.0000
481 INFUSION RELATED REACTION 1 0.0000
482 BLOOD PRESSURE DECREASED 1 0.0000
483 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
484 WEIGHT DECREASED 4 0.0000
485 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
486 DRUG INEFFECTIVE 18 0.0000
487 PAIN IN EXTREMITY 4 0.0000
488 EPISTAXIS 1 0.0000
489 UNEVALUABLE EVENT 1 0.0000
490 INCORRECT DOSE ADMINISTERED 3 0.0000
491 DRUG INTERACTION 2 0.0000
492 INJECTION SITE BRUISING 1 0.0000
493 THROMBOSIS 1 0.0000
494 CONFUSIONAL STATE 2 0.0000
495 PNEUMONIA 4 0.0000
496 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
497 TREATMENT FAILURE 1 0.0000
498 FALL 4 0.0000
499 MUSCULOSKELETAL STIFFNESS 1 0.0000
500 PAIN 7 0.0000
501 TACHYCARDIA 1 0.0000
502 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
503 ADVERSE EVENT 1 0.0000
504 BREAST CANCER 1 0.0000
505 NEUROPATHY PERIPHERAL 1 0.0000
506 GAIT DISTURBANCE 2 0.0000
507 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
508 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
509 LOSS OF CONSCIOUSNESS 1 0.0000
510 INFECTION 1 0.0000
511 HOSPITALISATION 1 0.0000
512 TREMOR 1 0.0000
513 PYREXIA 2 0.0000
514 BLOOD GLUCOSE INCREASED 1 0.0000
515 OVERDOSE 1 0.0000
516 ASTHENIA 1 0.0000
517 DEATH 1 0.0000